menu ☰
menu ˟

Q&A: A closer look at class effects of SGLT2 inhibitors on CV outcomes in diabetes

18 Dec 2018
An expert consensus decision pathway recently published by the American College of Cardiology highlights studies that show SGLT2 inhibitors significantly improve CV outcomes in patients with type 2 diabetes and atherosclerotic CVD.Research presented ...

Click here to view the full article which appeared in

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.